Lowered IL‐37 gene expression and elevated IL‐37‐producing tissue‐resident immune cells in psoriasis lesional biopsies
Pathology International · 2023
DOI: 10.1111/pin.13364 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology International, 2023. Verfasst von Aini Wulamujiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Histology and Embryology, Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey. Hauptthemen laut MEDLINE: Psoriasis, Interleukin-1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Psoriasis is an immune cell‐dependent chronic autoimmune skin disorder. Interleukin 37 (IL‐37) is a cytokine belonging to the IL‐1 family that shows anti‐inflammatory and protective effects in various mouse models of psoriasis. Even though various animal models are used to investigate the pathogenic mechanisms of psoriasis, human clinical studies are still needed to make up for the deficiencies, as animal models generally do not exhibit the complex phenotypic features of human psoriasis. Our study aims to demonstrate the relationship between IL‐37‐producing tissue‐resident immune cells with the pathogenesis of psoriasis. The present study was performed on 28 psoriasis patients and 17 healthy volunteers. The ability of anti‐inflammatory cytokine IL‐37 to impede inflammation and regulate metabolic pathways was assessed by real‐time quantitative polymerase chain reaction. Finally, immunofluorescence double staining for CD4 + IL‐37b + , CD68 + IL‐37b + , and (forkhead box protein P3) Foxp3 + IL‐37b + was performed. The proportion of CD4 + IL‐37b + T cells, CD68 + IL‐37b + macrophages, and Foxp3 + IL‐37b + T regulatory (Treg) cells was significantly increased in the psoriasis group compared to the control group. IL‐37 gene expression was downregulated in psoriasis when contrasted to the control group. Our findings disclosed that IL‐37‐producing tissue‐resident immune cells might be involved in the pathogenesis of psoriasis, and thus may be a therapeutic target for individuals with psoriasis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Histology and Embryology, Hamidiye International School of Medicine, University of Health Sciences, Istanbul, Turkey.
- Department of Pathology, Goztepe Training and Research Hospital, Istanbul, Turkey.
- Department of Medical Biology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Turkey.
- Department of Histology and Embryology, Hamidiye School of Medicine, University of Health Sciences, Istanbul, Turkey.
- Department of Molecular Biology and Genetics, Hamidiye Institute of Health Science, University of Health Sciences, Istanbul, Turkey.
- Experimental Medicine Application & Research Center, Validebag Research Park, University of Health Sciences, Istanbul, Turkey.
ORCID-Profile: Seyma Ozkanli, Ender Coskunpinar, Halime Tuba Canbaz, Gamze Yesilay, Muhammetnur Tekayev
Zitieren
APA
Wulamujiang, A., Ozkanli, S., Coskunpinar, E., Canbaz, H. T., Yesilay, G., Tekayev, M., & Sevgin, K. (2023). Lowered IL‐37 gene expression and elevated IL‐37‐producing tissue‐resident immune cells in psoriasis lesional biopsies. Pathology International. https://doi.org/10.1111/pin.13364
Vancouver
Wulamujiang A, Ozkanli S, Coskunpinar E, Canbaz HT, Yesilay G, Tekayev M, et al. Lowered IL‐37 gene expression and elevated IL‐37‐producing tissue‐resident immune cells in psoriasis lesional biopsies. Pathology International. 2023. doi:10.1111/pin.13364
BibTeX
@article{Wulamujiang2023,
author = {Wulamujiang, Aini and Ozkanli, Seyma and Coskunpinar, Ender and Canbaz, Halime Tuba and Yesilay, Gamze and Tekayev, Muhammetnur and Sevgin, Kubra},
title = {Lowered IL‐37 gene expression and elevated IL‐37‐producing tissue‐resident immune cells in psoriasis lesional biopsies},
journal = {Pathology International},
year = {2023},
doi = {10.1111/pin.13364}
}
EUVIMED